A rare case of carcinoma erysipeloides/en cuirasse secondary to metastatic cutaneous apocrine adenocarcinoma
Open Access
- 9 May 2026
- journal article
- case report
- Published by Elsevier in JAAD Case Reports
- Vol. 73, 118-121
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of Cutaneous Adnexal Carcinoma With RadiotherapyAmerican Journal of Clinical Oncology, 2025
- Carcinoma erysipeloides, a case-report and review of the sixty-nine cases in the literatureThe American Journal of the Medical Sciences, 2024
- Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II TrialJournal of Clinical Oncology, 2024
- Carcinoma en CuirasseJAMA Dermatology, 2023
- Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane ChemotherapyJAMA Dermatology, 2016
- Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literatureWorld Journal of Surgical Oncology, 2015
- Cutaneous apocrine adenocarcinoma: Defining epidemiology, outcomes, and optimal therapy for a rare neoplasmJournal of Surgical Oncology, 2011
- Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.Archives of Pathology & Laboratory Medicine, 2007
- Panels of Immunohistochemical Markers Help Determine Primary Sites of Metastatic AdenocarcinomaArchives of Pathology & Laboratory Medicine, 2007
- Apocrine Adenocarcinoma Presenting as a Large Ulcerated Axillary MassDermatologic Surgery, 1997